» Articles » PMID: 8795569

The Influence of Iron Chelators on the Accumulation of Protoporphyrin IX in 5-aminolaevulinic Acid-treated Cells

Overview
Journal Br J Cancer
Specialty Oncology
Date 1996 Sep 1
PMID 8795569
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Human adenocarcinoma cells of the line WiDr and Chinese hamster lung fibroblasts of the line V79 were treated with 5-aminolaevulinic acid (5-ALA) and exposed to light. The effects of the iron chelators ethylenediaminetetraacetic acid (EDTA) and desferrioxamine (DEF) were assessed. Both cell lines were treated with various concentrations of 5-ALA in the presence or absence of the iron chelators for 4 h in serum-free medium. The accumulation of protoporphyrin IX (PpIX) reached a maximum level at 1 mM 5-ALA in WiDr cells [280 ng PpIX (mg protein x 4 h-1] and at 0.1 mM 5-ALA in V79 cells [55 ng PpIX (mg protein x 4 h)-1]. PpIX was the only fluorescing porphyrin in these cells after 5-ALA treatment alone or in combination with the chelators. The iron chelators did not influence the intracellular localisation pattern of PpIX in 5-ALA-treated cells. While both chelators enhanced the accumulation of PpIX in 5-ALA-treated cells, DEF was found to be superior at equal concentrations. A linear relationship between the applied concentration of DEF and the DEF-induced increase in PpIX accumulation was observed in double-reciprocal plots. The intercepts of the regression lines with the ordinate indicate that the ferrochelatase is saturated with PpIX when the 5-ALA concentration exceeds 0.3 mM and 0.05 mM in WiDr and V79 cells respectively. The DEF-induced enhancement of PpIX accumulation in 5-ALA-treated cells was cell line and 5-ALA concentration dependent. At a 5-ALA concentration inducing a maximum level of PpIX accumulation, inhibition of ferrochelatase activity enhanced the PpIX accumulation 3- and 1.4-fold in V79 and WiDr cells respectively. The relative gain in PpIX accumulation increased with decreasing concentration of 5-ALA. In cells treated with the lowest concentrations of 5-ALA used in this study, DEF enhanced PpIX accumulation 44- and 3.5-fold in V79 and WiDr cells respectively. The iron chelator-induced increase in cellular PpIX accumulation was followed by a similar increase in sensitivity to photoinactivation. The ferrochelatase inhibitor dihydropyridine 3,5-diethoxycarbonyl-1,4-dihydrocollidine reduced the accumulation of PpIX in both cell lines.

Citing Articles

Enhancement of 5-Aminolevulinic Acid-Mediated Photodynamic Inactivation of Using Phosphoric and Bisaminophosphinic Acids as Permeabilizing Agents.

Zdubek A, Maliszewska I, Grabowiecka A, Kowalczyk R, Turek B ACS Omega. 2024; 9(49):48629-48641.

PMID: 39676993 PMC: 11635689. DOI: 10.1021/acsomega.4c07696.


On the Possibility of Using 5-Aminolevulinic Acid in the Light-Induced Destruction of Microorganisms.

Zdubek A, Maliszewska I Int J Mol Sci. 2024; 25(7).

PMID: 38612403 PMC: 11011456. DOI: 10.3390/ijms25073590.


Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro.

Reburn C, Gawthorpe G, Perry A, Wood M, Curnow A Pharmaceutics. 2023; 15(12).

PMID: 38140009 PMC: 10747273. DOI: 10.3390/pharmaceutics15122668.


Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.

Hussain Z, Qi Q, Zhu J, Anderson K, Ma X Pharmacol Ther. 2023; 248:108487.

PMID: 37392940 PMC: 10529234. DOI: 10.1016/j.pharmthera.2023.108487.


5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.

Howley R, Chandratre S, Chen B Bioengineering (Basel). 2023; 10(4).

PMID: 37106683 PMC: 10136048. DOI: 10.3390/bioengineering10040496.


References
1.
Taketani S, Tokunaga R . Purification and substrate specificity of bovine liver-ferrochelatase. Eur J Biochem. 1982; 127(3):443-7. DOI: 10.1111/j.1432-1033.1982.tb06892.x. View

2.
Ortiz de Montellano P, Beilan H, Kunze K . N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin. J Biol Chem. 1981; 256(13):6708-13. View

3.
Malik Z, Lugaci H . Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 1987; 56(5):589-95. PMC: 2001902. DOI: 10.1038/bjc.1987.246. View

4.
Schoenfeld N, Epstein O, Lahav M, Mamet R, Shaklai M, Atsmon A . The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett. 1988; 43(1-2):43-8. DOI: 10.1016/0304-3835(88)90211-x. View

5.
Rossi E, Attwood P, Costin K . Inhibition of human lymphocyte ferrochelatase activity by hemin. Biochim Biophys Acta. 1990; 1038(3):375-81. DOI: 10.1016/0167-4838(90)90251-a. View